Steris (STE) EPS (Weighted Average and Diluted) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.29% |
| Dec 31, 2025 | 1.03% |
| Sep 30, 2025 | 8.38% |
| Jun 30, 2025 | 25.17% |
| Mar 31, 2025 | -18.29% |
| Dec 31, 2024 | 15.89% |
| Sep 30, 2024 | 7.09% |
| Jun 30, 2024 | 14,200.00% |
| Mar 31, 2024 | -100.70% |
| Dec 31, 2023 | 18.33% |
| Sep 30, 2023 | -8.40% |
| Jun 30, 2023 | -28.42% |
| Mar 31, 2023 | 47.58% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 4.20% |
| Jun 30, 2022 | 128.85% |
| Mar 31, 2022 | -63.38% |
| Dec 31, 2021 | 105.80% |
| Sep 30, 2021 | 387.50% |
| Jun 30, 2021 | -123.53% |
| Mar 31, 2021 | -23.31% |
| Dec 31, 2020 | 8.13% |
| Sep 30, 2020 | 17.14% |
| Jun 30, 2020 | -26.57% |
| Mar 31, 2020 | 16.26% |
| Dec 31, 2019 | 10.81% |
| Sep 30, 2019 | 11.00% |
| Jun 30, 2019 | -21.26% |
| Mar 31, 2019 | 126.79% |
| Dec 31, 2018 | -38.46% |
| Sep 30, 2018 | 10.98% |
| Jun 30, 2018 | -4.65% |